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Abstract	Historically, a single research project involving numerous practice-based research networks (PBRNs)
required multiple institutional review boards (IRBs) to be involved in approval of the project. However,
to avoid redundancies, federal IRB regulations now allow cooperative research projects that involve
more than one institution to use reasonable methods of cooperative IRB review and to cede authority
for review and oversight of the project to a single lead IRB. Through ceding, a lead IRB has the
authority for review and oversight of the project delegated by all participating sites’ IRBs and becomes
the IRB of record for the ceded sites. In the conduct of cooperative research projects, each institution
or primary care office site is still responsible for safeguarding the rights and welfare of human subjects
and for complying with applicable regulations. The purpose of this report is to delineate the process,
including cooperation and effort of personnel, for accomplishing IRB approval for the Implementing
Networks’ Self-management Tools Through Engaging Patients and Practices (INSTTEPP) clinical trial.
This process involved 4 PBRNs, 16 family physician offices, 4 academic institution’s IRBs, and 4 family
practice office external IRBs ceding to the lead IRB. Once ceding was accomplished, subsequent IRB
modifications and continuing reviews were the responsibility of the lead IRB, ultimately saving time for
all participants and keeping the project on schedule. (J Patient Cent Res Rev. 2018;5:304-310.)
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Project Initiation
The Meta-Network Learning and Research Center
(Meta-LARC) is a collaboration of 6 well-established
practice-based research networks (PBRNs) whose

*Implementing Networks Self-management Tools Through Engaging
Patients and Practices
The Meta-Network Learning and Research Center is comprised of Duke
Primary Care Research Consortium, Iowa Research Network, Oregon
Rural Practice-based Research Network, Quebec Practice-Based
Research Network, State Networks of Colorado Ambulatory Practices
and Partners, and Wisconsin Research and Education Network.
†
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mission is to sustain a consortium of PBRNs dedicated
to increasing the quality, effectiveness, and safety
of primary care through accelerated research and
collaborative learning. Meta-LARC provides a robust
infrastructure capable of managing large clinical trials
and practice transformation initiatives. In September
2013, Meta-LARC received funding from the Agency
for Healthcare Research and Quality to conduct a study
titled “Implementing Networks’ Self-management
Tools Through Engaging Patients and Practices
(INSTTEPP).”1 The purpose of INSTTEPP was to
provide an enhanced practice-patient partnership
model, through boot camp translation,2 to increase
patient self-management skills and engagement
Brief Report

for improving their health using the agency’s selfmanagement support tools. The aim of this brief
report is to delineate the process for accomplishing
institutional review board (IRB) approval for the
INSTTEPP project.

IRB, as multiple IRB applications would be redundant
and cause unnecessary work.5 Each family physician
office may have its own IRB or may have no IRB
oversight. Cooperative research would minimally
involve one PBRN with multiple physician offices.6

In the spirit of accelerating PBRN research, 4
participating Meta-LARC research teams — the Oregon
Rural Practice-based Research Network (ORPRN),
Iowa Research Network (IRENE), State Networks
of Colorado Ambulatory Practices and Partners
(SNOCAP), and Wisconsin Research and Education
Network (WREN) — endeavored to establish a
cooperative research agreement for INSTTEPP wherein
the participating PBRNs (Table 1) would cede to the
lead institution’s IRB. Through ceding, the lead IRB
has the authority for review and oversight of the project
delegated by all participating sites’ IRBs and becomes
the IRB of record. The goal of the ceding process was
to make human subjects protection review of research
across sites as efficient and timely as possible while still
recognizing the importance of each participating IRB’s
responsibility for ensuring the safety, rights, and welfare
of research subjects. Practice-based research focuses
on research conducted typically in offices of clinicians
practicing in the community,3 and this particular study
involved 16 family physician offices in four states.

To avoid duplication of review efforts, an IRB may
choose to conduct joint reviews, rely on the review
of another qualified IRB, or make other arrangements
to establish oversight responsibilities. In making this
decision, an IRB must determine if an institution is
engaged in human subjects research. Once an IRB
determines that an outside institution’s IRB can
provide oversight, an IRB Authorization Agreement or
other equivalent agreement is signed. In the conduct
of cooperative research projects, each institution
or primary care office site is still responsible for
safeguarding the rights and welfare of human subjects
and for complying with applicable regulations.

Cooperative Research
The U.S. Department of Health and Human Services
and Food and Drug Administration provide federal
regulations (45 CFR 46.114 and 21 CFR 56.114,
respectively) that allow cooperative research projects
involving more than one institution to use reasonable
methods of cooperative IRB review4 to cede authority
for review and oversight of the project to a single lead

Ceding Process for the INSTTEPP Project
The lead research team for this study was based at the
University of Colorado (home of the SNOCAP PBRN).
SNOCAP’s research activity falls under the auspices
of the Colorado Multiple Institutional Review Board
(COMIRB). The lead investigator and 3 collaborating
investigators agreed to use a cooperative research
project review agreement. All investigators initiated
conversations with their respective IRB chairs about
any particular factors to check. The lead investigator
met with the COMIRB director to discuss this study
and determine if it was appropriate for COMIRB to
serve as the IRB of record. Upon approval through a
modification, COMIRB agreed to be the oversight IRB
for the other 3 PBRNs. For INSTTEPP, each PBRN
was expected to recruit 4 family physician offices

Table 1. Original PBRN Locations, Institutional Affiliations, and Principal Investigator
Network

Location

Institutional Affiliation

PBRN Director

IRENE*

Iowa City, IA

University of Iowa

Barcey Levy

Portland, OR

Oregon Health & Science University

Lyle Fagnan

Denver, CO

University of Colorado

Donald Nease

Madison, WI

University of Wisconsin

David Hahn

ORPRN*
SNOCAP*

†

WREN*

*Practice-based research network (PBRN) participating in research study.
†

Lead team for the INSTTEPP study.1
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to participate in the study. At the time of approval,
COMIRB determined that the 4 SNOCAP participating
physician offices were not conducting human subjects
research, only the research team itself was conducting
human subjects research.

an IRB, and no IRB paperwork was completed.
Once each authorization agreement was signed by a
respective site and after the COMIRB chair signature
was obtained, each IRB and office contact was given a
copy of the fully signed document.

Upon approval to serve as the IRB of record,
COMIRB provided approval documentation for
the lead investigator to send to the collaborating
investigators. The lead investigator shared the
COMIRB application, approval documentation, and
IRB Authorization Agreement (Appendix A) with each
of the 3 participating PBRN investigators. In turn, the
collaborating investigators submitted the approved
application material to their institutions’ respective
IRBs. The IRB submission process varied by each
PBRN as described hereinafter.

ORPRN Ceding
ORPRN research is reviewed by the Oregon Health &
Science University Research Integrity Office, which has
established cooperative agreements to cede or accept
ceded oversight from institutions. For INSTTEPP, a
new IRB application was created as a request to waive
oversight to another IRB. The office reviewed the
application, and the request was approved for three
practices not having a local IRB and the ORPRN
research staff; this process took about 28 days. The same
office deemed the research staff engaged in research but
not the staff at participating practices.

IRENE Ceding
At the University of Iowa (home of the IRENE
PBRN), the collaborating investigator submitted
via email a description of the study, the COMIRBapproved application, the approval letter, and the IRB
Authorization Agreement. In addition to those materials,
the university’s IRB asked for associated study materials,
such as recruitment handouts and questionnaires, and
provided its version of an authorization agreement for
COMIRB to populate. The IRB deemed the project as
human subjects research for the research staff.
The IRENE PBRN recruited 4 family physician offices
to participate in the study. The first was a University
of Iowa office, in which office staff would provide
potential patients with study information and, if
authorization granted, would provide the potential
patients’ names and contact information to the
IRENE PBRN research staff to recruit for the study.
The office staff person was deemed to be engaged in
research, as she was providing personal information to
another person. The university’s IRB signed the IRB
Authorization Agreement and ceded to COMIRB.
Two other participating IRENE offices each had their
own IRB. Those office contacts were sent the COMIRBapproved application, approval letter, associated
materials, and IRB Authorization Agreement. They
submitted the materials to their respective IRBs, each
of which signed the IRB Authorization Agreement.
The fourth participating IRENE office did not have
306 JPCRR • Volume 5, Issue 4 • Fall 2018

A fourth practice had a local health system IRB
that had not ceded oversight to another IRB before.
However, to maintain a consistent process across
all PBRNs, ceding oversight was considered a
requirement for participation. After review of ceding
materials, that health system IRB determined that it
would be appropriate to cede oversight to COMIRB
and submitted an IRB Authorization Agreement, which
was accepted by COMIRB.
WREN Ceding
At the University of Wisconsin (home of the WREN
PBRN), there is a formal online application to defer
IRB review to another institution. In this submission,
an application for research had to be completed. The
university’s IRB reviewed the application, consent
document, and study protocol approved by the
proposed COMIRB. After reviewing the application
and modifying the information sheets and consent
forms to include WREN contacts, the university’s IRB
agreed to defer to COMIRB.
One of the 4 participating WREN physician offices had
its own IRB; the other 3 did not. The university’s IRB
deemed that the research staff was engaged in human
subjects research and that the office staff was not. The
participating office’s IRB reviewed the application from
COMIRB and talking points from WREN research staff
and also determined that its staff was not engaged in
human subjects research. WREN’s memorandum of
Brief Report

understanding provided information about ceding to
COMIRB for the 3 offices without IRBs and why their
clinics were not engaged in human subjects research but
rather WREN was engaged in human subjects research.
A summary of ceding results from all IRB applications
is shown in Figure 1.
Causes for Delays in the Ceding Process
Delays and exorbitant time drains are an inherent part
of most research projects and may be especially true
for IRB submissions. The COMIRB project submission
and final approval of all ceding to COMIRB took 145
days, with an additional 45 days of cooperative research

work done by the lead principal investigator (PI) prior
to submission. Studying the effects of local IRB review
on participation in national PBRN studies, researchers
found the median days to obtain approval was 81 days
for the Child Abuse Recognition Experience Study and
109 days for the Safety Check Study.6 In another review
of a 43-site study, IRB approval took a median of 286
days with a range of 52 to 798 days.7
Some causes of delays in the ceding process for this
INSTTEPP project:
• First time a PBRN participated in a ceding process.
• Online IRB application program isn’t capable of
accepting a ceding application.

Lead PI originates study
at University of Colorado

Submits IRB application to COMIRB requesting
COMIRB be the lead IRB

COMIRB approves application and provides
deferment agreements to PBRNs

COMIRB deemed SNOCAP
physician offices 1, 2, 3, 4
staff not conducting human
subjects research

IRENE applies to University of
Iowa (UI) IRB to cede

IRENE physician offices:
5 had UI IRB
6 had no IRB
7, 8 had external IRB

Office 5 signs
UI IAA

Office 6 staff not
conducting
human subjects
research

Offices 7, 8 external
IRB completes IAA,
cede to COMIRB

ORPRN applies to Oregon Health
& Science University IRB to cede

ORPRN physician offices:
9, 10, 11 had no IRB
12 had external IRB

Offices 9, 10, 11
staff not
conducting
human subjects
research

Office 12 external
IRB completes IAA,
cedes to COMIRB

WREN applies to University of
Wisconsin (UW) IRB to cede

WREN physician offices:
13, 14, 15 had no IRB
16 had external IRB

Offices 13, 14, 15
sign UW IAA,
cede to COMIRB

Office 16 external
IRB completes IAA,
cedes to COMIRB

Lead COMIRB assumes ongoing oversight responsibility
for four SNOCAP offices and all four PBRNs

Figure 1. Overview of practice-based research networks (PBRNs) and 16 office practices ceding to a lead

institutional review board (IRB). COMIRB, Colorado Multiple Institutional Review Board; IAA, IRB Authorization
Agreement; IRENE, Iowa Research Network; ORPRN, Oregon Rural Practice-based Research Network; PI,
principal investigator; SNOCAP, State Networks of Colorado Ambulatory Practices and Partners; WREN, Wisconsin
Research and Education Network.
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• Back and forth between the IRB(s) and study team
because of unclear or insufficient information.
• Different interpretations of the research protocol.
• Different role of office staff in recruiting subjects,
such as giving patients the study contact information
or giving patient names to study staff.
• Different IRB Authorization Agreement forms for
each institution.
• The process for final approval itself was lengthy.
Any IRB process involving study review implicates time
and cost. For IRENE involvement in INSTTEPP, the
study was reviewed by the University of Iowa IRB and 2
private physician office IRBs after COMIRB approval.
For ORPRN and WREN, the study was reviewed by
their respective university IRBs and 2 external IRBs for
participating physician offices. A total of 8 IRB reviews
were completed for this one study in 4 states.
The National Institutes of Health (NIH) released a policy
in 2016 (becoming effective in 2018) maintaining that,
when NIH studies are conducted at multiple sites, a
single primary IRB of record will be used.8 The goal is
to streamline IRB review, reduce administrative burden,
and reduce systemic inefficiencies. In 2017 the U.S.
Department of Health and Humans Services released the
Common Rule, which stated that institutions engaging
in cooperative research use a single primary IRB. The
cooperative research portion of the revised Common
Rule becomes effective in 2020.9 With this new policy
and rule, the ceding process will become common to
many IRBs and investigators, lending the process to
becoming more efficient over time.
Regardless of the ceding process, each PI and research
team member is responsible for ensuring that the
rights and welfare of study participants are protected.
Safeguarding participants from undue risk is the ethical
responsibility of everyone involved in the research.
The required IRB review process should provide an
external review of the study, ensuring all steps meet
the principles of justice, autonomy, and beneficence.
Identifying strategies to facilitate readiness for
multicenter projects, Blustein and colleagues found
that making a plan for early involvement in the IRB
process was helpful to facilitate 11 acute care hospitals
in a study.10 Other effective strategies were provision
of IRB application templates, modular approach to
308 JPCRR • Volume 5, Issue 4 • Fall 2018

study description, and reliance on conference calls to
collectively engage prospective investigators, local
IRB members, and the program office team.10
Continual communication among investigators and
project managers from the 4 PBRNs was crucial in
realizing the success of the IRB cooperative research.
The success of the ceding process for this project was
enhanced by the researchers and project coordinators
having worked together on other projects, having
networked at national PBRN meetings, and being
part of a PBRN research center (ie, Meta-LARC). In
addition, the lead COMIRB’s application was sent
to each of the PBRNs to use for each of their own
individual IRB reviews, which ensured continuity
across sites and sped the application process.10
Suggestions for enhancing multisite, multi-PBRN
research include 1) determine during the writing of the
proposal if the lead PI will have his or her respective
institution be the lead IRB and allow ceding from other
IRBs, 2) determine who is responsible for the IRB
application at each site, 3) schedule routine conference
calls regarding IRB application on a regular basis
until final approval is received, 4) include site PIs
and coordinators and a local IRB member on each
conference call, 5) provide the lead IRB’s application
template to each non-lead site, 6) notify potential sites
that IRB review is necessary for the study, and 7)
identify early on which participating PBRN physician
office sites have an IRB.
Conclusions
After the IRB approval process was completed at
each institution and all participating physician offices,
the Colorado Multiple Institutional Review Board
became the IRB of record for the INSTTEPP study. It
is responsible for continuing review as well as review
of subsequent modifications, amendments, and any
adverse events and unanticipated problems. For 15 of
the 16 physician offices, on-site staff were determined
to be not engaged in research for handing the study
information sheet to prospective subjects and not
trying to recruit the patient (Figure 1). If the potential
subject was interested, he or she was to call research
staff to inquire about the study.
A total of 8 IRB reviews were completed for this 1
study in 4 states. The entirety of project submission and
Brief Report

joint approval took 145 days. For this project, the lead
investigator and research team had the foresight to start
the IRB application 45 days prior to the project’s start
date. Continual communication between the 4 PBRN
investigators was crucial in successfully realizing IRB
approval of this cooperative research.
Undertaking this cooperative research endeavor taught
all involved — PBRN investigators, staff, participating
clinicians, and IRB members — that the process is
doable. It does require one lead person, probably at
the lead PBRN site, to keep communication flowing
in a timely manner. Learning about the cooperative
research process during the writing of a proposal and
when obtaining letters of support from participants
would enhance a project once ultimately funded.

Patient-Friendly Recap
• Research conducted in health systems and
physician offices carries subject protections that
are monitored by review boards.
• Multiple physician offices collaborating on a
research project may coordinate their review
process by ceding oversight to one institutional
review board (IRB).
• Although the review process for human subject
research is detailed and time-consuming to
ensure protection of patients, ceding to a
single primary IRB can help curtail redundant
regulatory hurdles and ease the burden on
researchers.
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Appendix A
IRB Authorization Agreement
Name of Institution or Organization Providing IRB Review (Institution A): University of
Colorado Denver
OHRP Federalwide Assurance (FWA) #: 00005070
IRB Registration #:
Panel A – IRB00000648
Panel B – IRB00000650
Panel C – IRB00000651
Panel D – IRB00002760
Panel S – IRB00006846
Name of Institution Relying on the Designated IRB (Institution B):
OHRP Federalwide Assurance (FWA) #:
The Officials signing below agree that __________________ may rely on the University of
Colorado Denver for review and continuing oversight of its human subject research described
below:
This agreement is limited to the following specific protocol(s): COMIRB #13-0349
Name of Research Project: Implementing Networks’ Self-management Tools Through Engaging
Patients and Practices (INSTTEPP)
Name of Principal Investigator: Donald Nease, MD
Sponsor or Funding Agency: Agency for Healthcare Research and Quality
Award Number, if any:
The review and continuing oversight performed by the designated IRB will meet the human
subject protection requirements of Institution B’s OHRP-approved FWA. The IRB at the
University of Colorado Denver will follow written procedures for reporting its findings and
actions to appropriate officials at Institution B. Relevant minutes of IRB meetings will be made
available to Institution B upon request. Institution B remains responsible for ensuring
compliance with the IRB’s determinations and with the terms of its OHRP-approved Assurance.
This document must be kept on file at both institutions and provided to OHRP upon request.
Signature of Signatory Official (University of Colorado Denver): ______________________
Date: ___________
Print Full Name:
Institutional Title: Vice Chancellor for Research
Signature of Signatory Official (Institution B): ___________________________
Date: ___________
Print Full Name:
Institutional Title:
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